The effect of local immunotherapy for breast cancer using a mixture of OK-432 and fibrinogen supplemented with activated macrophages

No abstract is available for this paper.

• Publication year

  1993

• Venue

  Biotherapy

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/BF01878153PMID 8068483
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Enhancement of rat hepatic macrophages by treatment with interleukin-2 and streptococcal preparation OK432, with reference to antitumor activity, soluble factor production and Ia expression

  2005cited by this paper
• Tumor-immunotherapy with the use of tumor-antigen-pulsed antigen-presenting cells

  2005cited by this paper
• Intrapleural administration of OK432 in cancer patients: Augmentation of autologous tumor killing activity of tumor-associated large granular lymphocytes

  2004cited by this paper
• A Cancer‐reactive Human Monoclonal Antibody Derived from a Colonic Cancer Patient Treated with Local Immunotherapy

  1993cited by this paper
• Augmentation of antitumor immunity in regional lymph nodes by local immunotherapy

  1993cited by this paper
• Adoptive Immunotherapy with Activated Macrophages Grown In Vitro from Blood Monocytes in Cancer Patients: A Pilot Study

  1992cited by this paper
• Establishment of cytotoxic CD4+ T cell clones from cancer patients treated by local immunotherapy

  1992cited by this paper
• The origin and function of tumor-associated macrophages.

  1992cited by this paper
• A Human Monoclonal Antibody Derived from Axillary Lymph Nodes of a Breast Cancer Patient Reactive to a Sulfated Glycolipid

  1992cited by this paper
• Use of a Local Immunotherapy as an Adjunctive Tool for the Generation of Human Monoclonal Antibodies from Regional Lymph Nodes of Colonic Cancer Patients

  1992cited by this paper
• Use of fibrinogen to enhance the antitumor effect of OK‐432. A new approach to immunotherapy for colorectal carcinoma

  1992cited by this paper
• Coexisting macrophage‐associated fibrin formation and tumor cell urokinase in squamous cell and adenocarcinoma of the lung tissues

  1991cited by this paper
• USE OF A RAPID MICROWAVE FIXATION TECHNIQUE FOR IMMUNOCYTOCHEMICAL DEMONSTRATION OF TUMOR NECROSIS FACTOR, INTERLEUKIN-1α, AND INTERLUEKIN-1β IN ACTIVATED HUMAN PERIPHERAL MONONUCLEAR CELLS

  1990cited by this paper
• Procoagulant activity of mononuclear phagocytes from different anatomical sites in patients with gynecological malignancies

  1990cited by this paper
• Adoptive transfer of tumor cytotoxic macrophages generated in vitro from circulating blood monocytes: a new approach to cancer immunotherapy.

  1990cited by this paper
• Therapeutic efficacy of sequential therapy with OK-432, cyclophosphamide, IL2-cultured lymphocytes andin vivo IL2 against advanced murine plasmacytoma

  1989cited by this paper
• Adoptive immunotherapy by pantropic killer cells recovered from OK-432-injected tumor sites in mice.

  1988cited by this paper
• Macrophages associated with murine tumours express plasminogen activator activity

  1988cited by this paper
• Macrophage migration in fibrin gel matrices. II. Effects of clotting factor XIII, fibronectin, and glycosaminoglycan content on cell migration.

  1988cited by this paper
• Production of tumor necrosis factor (TNF) by monocytes from cancer patients and healthy subjects induced by OK-432 in vitro, and its augmentation by human interferon gamma.

  1988cited by this paper
• Immunotherapy of murine sarcoma by adoptive transfer of resident peritoneal macrophages proliferating in culture.

  1988cited by this paper
• Clinical value of immunotherapy with the streptococcal preparation OK-432 in non-small cell lung cancer.

  1987cited by this paper
• Increased interleukin-1 and modulation of interleukin-2 production by murine macrophages and lymphocytes treated with LF 1695.

  1986cited by this paper
• Macrophage migration in fibrin gel matrices.

  1986cited by this paper
• Activated macrophage hybridomas secreting a cytotoxic factor.

  1986cited by this paper
• Macrophages and metastasis--a biological approach to cancer therapy.

  1985cited by this paper
• Clinical value of immunotherapy for lung cancer by the streptococcal preparation OK‐432

  1984cited by this paper
• [Oral administration of streptococcal preparation "OK 432 (picibanil)"--the second report: experimental studies on its absorption and the responses of the gut associated lymphoid tissue].

  1984cited by this paper
• Induction of neovascularization in vivo and endothelial proliferation in vitro by tumor-associated macrophages.

  1984cited by this paper
• New approach to management of malignant ascites with a streptococcal preparation, OK-432. I. Improvement of host immunity and prolongation of survival.

  1983cited by this paper
• New approach to management of malignant ascites with a streptococcal preparation, OK-432. II. Intraperitoneal inflammatory cell-mediated tumor cell destruction.

  1983cited by this paper
• Peritoneal adherent cell inhibit the generation of cytotoxic T lymphocytes with prostaglandin-mediated system.

  1982cited by this paper
• Suppression of lymphokine production by macrophages infiltrating murine virus‐induced tumors

  1979cited by this paper

• Fibrinogen

  2017cites this paper
• MODULATOR COMBINATIONS FOR TREATING BREAST CANCER

  2017cites this paper
• M1 macrophage infiltrations and histological changes in the liver after portal vein embolization using fibrinogen and OK432 in the rat.

  2016cites this paper
• Role of intratumoral infiltrating macrophages after transarterial immunoembolization for hepatocellular carcinoma

  2016cites this paper
• Surgical immune interventions for solid malignancies.

  2016cites this paper
• Combination by Hyperthermia and Immunotherapy: DC Therapy and Hyperthermia

  2016cites this paper
• Biological effect of OK-432 (picibanil) and possible application to dendritic cell therapy.

  2004cites this paper
• Biopolymers for Parenteral Drug Delivery in Cancer Treatment

  2004cites this paper
• Drug Delivery Systems in Cancer Therapy

  2004cites this paper
• Potent Stimuli Combined with Lipopolysaccaride and IFNγ May Improve Immunotherapy against HCC by Increasing the Maturation and Subsequent Immune Response of the Dendritic Cells

  2003cites this paper
• Intratumoral injection of dendritic cells derived in vitro in patients with metastatic cancer

  2000cites this paper
• Phase I trial of adoptive immunotherapy of cancer patients using monocyte-derived macrophages activated with interferon γ and lipopolysaccharide

  1997influential citation
• Monocyte/Macrophage Activation by Immunostimulators

  1996cites this paper